• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于模型的多分区聚类识别具有运动和非运动症状的帕金森病亚型。

Identifying Parkinson's disease subtypes with motor and non-motor symptoms via model-based multi-partition clustering.

机构信息

Computational Intelligence Group, Universidad Politécnica de Madrid, Madrid, Spain.

National Center of Epidemiology, Carlos III Institute of Health, Madrid, Spain.

出版信息

Sci Rep. 2021 Dec 8;11(1):23645. doi: 10.1038/s41598-021-03118-w.

DOI:10.1038/s41598-021-03118-w
PMID:34880345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8654994/
Abstract

Identification of Parkinson's disease subtypes may help understand underlying disease mechanisms and provide personalized management. Although clustering methods have been previously used for subtyping, they have reported generic subtypes of limited relevance in real life practice because patients do not always fit into a single category. The aim of this study was to identify new subtypes assuming that patients could be grouped differently according to certain sets of related symptoms. To this purpose, a novel model-based multi-partition clustering method was applied on data from an international, multi-center, cross-sectional study of 402 Parkinson's disease patients. Both motor and non-motor symptoms were considered. As a result, eight sets of related symptoms were identified. Each of them provided a different way to group patients: impulse control issues, overall non-motor symptoms, presence of dyskinesias and pyschosis, fatigue, axial symptoms and motor fluctuations, autonomic dysfunction, depression, and excessive sweating. Each of these groups could be seen as a subtype of the disease. Significant differences between subtypes (P< 0.01) were found in sex, age, age of onset, disease duration, Hoehn & Yahr stage, and treatment. Independent confirmation of these results could have implications for the clinical management of Parkinson's disease patients.

摘要

帕金森病亚型的识别有助于了解潜在的疾病机制,并提供个性化的管理。虽然聚类方法以前曾用于亚组分析,但由于患者并不总是符合单一类别,因此它们报告的通用亚型在实际实践中相关性有限。本研究的目的是假设根据某些相关症状集,患者可以以不同的方式分组,从而确定新的亚型。为此,一种新的基于模型的多分区聚类方法应用于来自国际、多中心、横断面研究的 402 名帕金森病患者的数据。同时考虑了运动和非运动症状。结果确定了 8 组相关症状。每组症状都提供了一种不同的分组方式:冲动控制问题、整体非运动症状、是否存在异动症和精神症状、疲劳、轴性症状和运动波动、自主神经功能障碍、抑郁和过度出汗。这些组中的每一个都可以被视为疾病的一种亚型。在性别、年龄、发病年龄、病程、Hoehn & Yahr 分期和治疗方面,各亚型之间存在显著差异(P<0.01)。这些结果的独立证实可能对帕金森病患者的临床管理具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3053/8654994/2c00e33780c4/41598_2021_3118_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3053/8654994/2c00e33780c4/41598_2021_3118_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3053/8654994/2c00e33780c4/41598_2021_3118_Fig1_HTML.jpg

相似文献

1
Identifying Parkinson's disease subtypes with motor and non-motor symptoms via model-based multi-partition clustering.基于模型的多分区聚类识别具有运动和非运动症状的帕金森病亚型。
Sci Rep. 2021 Dec 8;11(1):23645. doi: 10.1038/s41598-021-03118-w.
2
Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.帕金森病亚型的临床标准:生物标志物和纵向进展。
Brain. 2017 Jul 1;140(7):1959-1976. doi: 10.1093/brain/awx118.
3
Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life.帕金森病多模态综合治疗改善运动症状、抑郁和生活质量。
J Neurol. 2020 Apr;267(4):954-965. doi: 10.1007/s00415-019-09657-7. Epub 2019 Dec 3.
4
Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries.五个欧洲国家中存在运动波动和异动症的帕金森病患者的生活质量
Parkinsonism Relat Disord. 2014 Sep;20(9):969-74. doi: 10.1016/j.parkreldis.2014.06.001. Epub 2014 Jun 10.
5
Comparison of two motor subtype classifications in de novo Parkinson's disease.两种新发帕金森病运动亚型分类的比较。
Parkinsonism Relat Disord. 2018 Sep;54:74-78. doi: 10.1016/j.parkreldis.2018.04.021. Epub 2018 Apr 18.
6
Risk and course of motor complications in a population-based incident Parkinson's disease cohort.基于人群的帕金森病发病队列中运动并发症的风险及病程
Parkinsonism Relat Disord. 2016 Jan;22:48-53. doi: 10.1016/j.parkreldis.2015.11.007. Epub 2015 Nov 6.
7
Non-motor symptoms in early Parkinson's disease with different motor subtypes and their associations with quality of life.早期帕金森病不同运动亚型的非运动症状及其与生活质量的关系。
Eur J Neurol. 2019 Mar;26(3):400-406. doi: 10.1111/ene.13803. Epub 2018 Sep 27.
8
A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms.帕金森病疼痛的双中心研究及其与其他非运动症状的关系。
J Parkinsons Dis. 2020;10(4):1817-1825. doi: 10.3233/JPD-202088.
9
Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study.抗帕金森病药物的使用因帕金森病亚型而异:一项队列研究。
Parkinsonism Relat Disord. 2021 Jun;87:137-141. doi: 10.1016/j.parkreldis.2021.04.023. Epub 2021 May 6.
10
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation.COPPADIS-2015(西班牙帕金森病患者队列研究,2015 年):这是一个正在进行的全球性帕金森病项目,涉及超过 1000 名受试者,旨在研究疾病进展情况。本研究报告了基线评估结果。
Eur J Neurol. 2019 Nov;26(11):1399-1407. doi: 10.1111/ene.14008. Epub 2019 Jul 4.

引用本文的文献

1
Pain in Parkinson's disease is impacted by motor complications, anxiety and sleep disturbances.帕金森病中的疼痛受运动并发症、焦虑和睡眠障碍的影响。
Eur J Pain. 2025 Feb;29(2):e4765. doi: 10.1002/ejp.4765.
2
Exploring Motor-Cognitive Interference Effects and the Influence of Self-Reported Physical Activity on Dual-Task Walking in Parkinson's Disease and Healthy Older Adults.探索帕金森病患者和健康老年人运动认知干扰效应以及自我报告的身体活动对双任务步行的影响。
Brain Sci. 2025 Jan 25;15(2):114. doi: 10.3390/brainsci15020114.
3
Integrating Big Data, Artificial Intelligence, and motion analysis for emerging precision medicine applications in Parkinson's Disease.

本文引用的文献

1
Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson's Disease: A Longitudinal Analysis of Two International Cohorts.便秘与新发帕金森病认知障碍的发展相关:两个国际队列的纵向分析。
J Parkinsons Dis. 2021;11(3):1209-1219. doi: 10.3233/JPD-212570.
2
Parkinson's Disease Subtypes: Critical Appraisal and Recommendations.帕金森病亚型:批判性评价与建议。
J Parkinsons Dis. 2021;11(2):395-404. doi: 10.3233/JPD-202472.
3
Co-occurrence of apathy and impulse control disorders in Parkinson disease.帕金森病中淡漠与冲动控制障碍的共现
整合大数据、人工智能和运动分析,用于帕金森病新兴的精准医学应用。
J Big Data. 2024;11(1):155. doi: 10.1186/s40537-024-01023-3. Epub 2024 Oct 30.
4
Novel perspective of therapeutic modules to overcome motor and nonmotor symptoms in Parkinson's disease.克服帕金森病运动和非运动症状的治疗模块新视角。
AIMS Neurosci. 2024 Sep 6;11(3):312-340. doi: 10.3934/Neuroscience.2024020. eCollection 2024.
5
Nonmotor Symptoms and Impulse Control Disorders in Parkinson's Disease Patients in India: A Cross-sectional Study.印度帕金森病患者的非运动症状和冲动控制障碍:一项横断面研究。
Ann Afr Med. 2024 Jul 1;23(3):400-405. doi: 10.4103/aam.aam_198_23. Epub 2024 Jun 8.
6
Disease progression in proposed brain-first and body-first Parkinson's disease subtypes.帕金森病脑优先和身体优先亚型中的疾病进展。
NPJ Parkinsons Dis. 2024 Jun 4;10(1):111. doi: 10.1038/s41531-024-00730-1.
7
Non-motor symptoms associated with progressive loss of dopaminergic neurons in a mouse model of Parkinson's disease.帕金森病小鼠模型中与多巴胺能神经元渐进性丧失相关的非运动症状。
Front Neurosci. 2024 Apr 30;18:1375265. doi: 10.3389/fnins.2024.1375265. eCollection 2024.
8
Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson's Disease.开发治疗帕金森病非多巴胺能策略的未来方向
Curr Neuropharmacol. 2024;22(10):1606-1620. doi: 10.2174/1570159X21666230731110709.
9
Two distinct trajectories of clinical and neurodegeneration events in Parkinson's disease.帕金森病临床和神经退行性变事件的两种不同轨迹。
NPJ Parkinsons Dis. 2023 Jul 13;9(1):111. doi: 10.1038/s41531-023-00556-3.
10
The noradrenergic subtype of Parkinson disease: from animal models to clinical practice.帕金森病的去甲肾上腺素能亚型:从动物模型到临床实践。
Nat Rev Neurol. 2023 Jun;19(6):333-345. doi: 10.1038/s41582-023-00802-5. Epub 2023 May 4.
Neurology. 2020 Nov 17;95(20):e2769-e2780. doi: 10.1212/WNL.0000000000010965. Epub 2020 Oct 1.
4
Therapy of Parkinson's Disease Subtypes.帕金森病亚型的治疗。
Neurotherapeutics. 2020 Oct;17(4):1366-1377. doi: 10.1007/s13311-020-00894-7.
5
Factor Analysis and Clustering of the Movement Disorder Society-Non-Motor Rating Scale.运动障碍学会非运动症状评定量表的因子分析与聚类。
Mov Disord. 2020 Jun;35(6):969-975. doi: 10.1002/mds.28002. Epub 2020 Mar 27.
6
Diagnosis and Treatment of Parkinson Disease: A Review.帕金森病的诊断与治疗:综述。
JAMA. 2020 Feb 11;323(6):548-560. doi: 10.1001/jama.2019.22360.
7
Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of Dopamine.帕金森病性精神病中的药物与疾病效应:重新审视多巴胺的作用
Mov Disord Clin Pract. 2019 Nov 11;7(1):32-36. doi: 10.1002/mdc3.12851. eCollection 2020 Jan.
8
Subtyping of Parkinson's Disease - Where Are We Up To?帕金森病的亚型分类——我们目前进展如何?
Aging Dis. 2019 Oct 1;10(5):1130-1139. doi: 10.14336/AD.2019.0112. eCollection 2019 Oct.
9
The movement disorder society nonmotor rating scale: Initial validation study.运动障碍学会非运动症状评定量表:初步验证研究。
Mov Disord. 2020 Jan;35(1):116-133. doi: 10.1002/mds.27862. Epub 2019 Sep 30.
10
Orthostatic hypotension in Parkinson disease: A 7-year prospective population-based study.帕金森病患者的直立性低血压:一项 7 年的前瞻性基于人群的研究。
Neurology. 2019 Oct 15;93(16):e1526-e1534. doi: 10.1212/WNL.0000000000008314. Epub 2019 Sep 16.